IP Library Patent Application 17456342
Patent Application
App. No. 17/456,342

TRANSLOCATION CONTROL ELEMENTS, REPORTER CODES, AND FURTHER MEANS FOR TRANSLOCATION CONTROL FOR USE IN NANOPORE SEQUENCING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/456,342
Abstract

Phosphoramidate-based monomers are provided for use in the synthesis of expandable polymers for nanopore-based sensing. Such monomers comprising a reporter construct that contain a first reporter code, a symmetrical chemical brancher bearing a translocation control element, and a second reporter code, wherein the ends of the reporter construct are attached to phosphoramidate-nucleoside. Related methods and products are also provided.

Claims (25)

1 . A compound having the following structure:

wherein

R is OH or H;

nucleobase is adenine, cytosine, guanine, thymine, uracil or a nucleobase analog;

reporter construct is a polymer having a first end and a second end, and comprising, in series from the first end to the second end, a first reporter code, a symmetrical chemical brancher bearing a translocation control element, and a second reporter code;

linker A joins the oxygen atom of the alpha phosphoramidate to the first end of the reporter construct;

linker B joins the nucleobase to the second end of the reporter construct; and wherein

the translocation control element is a polymer comprising two or more repeat units selected from: 1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b), 1,3-O-bis(phosphodiester)-2-(4-Me-O-PEG3)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35b), 1,3-O-bis(phosphodiester)-2s-O-mPEG6-propane (compound 12c), 1,2-O-bis(phosphodiester)-3-O-mPEG2-propane (compound 16), 2,3-O-bis(phosphodiester)-1-(5-benzofuran)-propane (compound 20i), 1,2-O-bis(phosphodiester)-3-(4-methylpiperazine-1-yl)-propane (compound 20j), 2,3-O-bis(phosphodiester)-1-(N1-(2-Me-5-nitroindole)-propane (compound 20g), 1,8-O-bis(phosphodiester)-N,N-Diethylpiperazine (compound 26h), 1,2-O-bis(phosphodiester)-3-(4-(Me-O-PEG3-O-Bz)-1-(1,2,3-triazole))-propane (compound 31d), 1,3-O-bis(phosphodiester)-2s-O-(4-(Me-O-PEG2)-1-(Et-OBz)-1,2,3-triazole)-propane (compound 35a), 1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35c), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG7)-1-(Et-OBz)-1,2,3-triazole)-propane (compound 35d), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG3)-1-(Me-acetate)-1,2,3-triazole)-propane (compound 35e), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG3)-1-(Et-2,2,2-Tris-(Me-O-Bz))-1,2,3-triazole)-propane (compound 37a), 1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-2,2,2-Tris-(Me-O—Ac))-1,2,3-triazole)-propane (compound 37b), 1,3-O-bis(phosphodiester-2S—O-(PEG4-O-Bz)-propane (compound 38b), 1,3-O-bis(phosphodiester-2,2-bis(Me-O-mPEG2)-propane (compound 45b), 1,3-O-bis(phosphodiester-2,2-bis(4-(Me-O-PEG2-O-Me)-1-(Et-O-Bz)-1,2,3-triazole)-propane (compound 47f), 1,3-O-bis(phosphodiester-2,2-bis(4-(Me-O-PEG3-O-Me)-1-(Et-O-Bz)-1,2,3-triazole)-propane (compound 47g), 1,3-O-bis(phosphodiester-2,2-bis(4-(Me-O-PEG3-O-Me)-1-(Et-2,2,2-Tris-(Me-O-Bz))-1,2,3-triazole)-propane (compound 47i), or 1,3-O-bis(phosphodiester-2,2-bis(1-Me-4-(Me-O-PEG2-O-Bz)-1,2,3-triazole)-propane (compound 52).

2 . The compound of claim 1 , wherein the symmetrical chemical brancher is selected from 1,2,3-O-tris-(phosphosphodiester)-propane, 1,3-bis-(5-O-phosphodiester-pentylamido)-2-O-phosphodiester-propane, and 1,4,7-O-tris-(phosphodiester)-heptane.

3 . The compound of claim 1 , wherein the symmetrical chemical brancher is 1,2,3-O-tris-(phosphosphodiester)-propane.

4 . The compound of claim 1 , wherein the translocation control element is a polymer comprising two or more repeat units selected from Table 1A.

5 . The compound of claim 1 , wherein the translocation control element is a polymer comprising two or more repeat units selected from 1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b) and 1,3-O-bis(phosphodiester)-2-(4-Me-O-PEG3)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35b).

6 . The compound of claim 1 , wherein the translocation control element is a polymer comprising the following sequence: [(1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b))]n1[(1,3-O-bis(phosphodiester)-2-(4-Me-O-PEG3)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35b))]n2, wherein n1 is from 0 to 6 and n2 is from 6 to 10.

7 . The compound of claim 1 , wherein the first and second reporter codes are identical.

8 . The compound of claim 1 , wherein the first and second reporter codes are polymers comprising two or more repeat units selected from: hexaethylene glycol (D), ethane (L), triaethylene glycol (X), 1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b), 1,3-O-bis(phosphodiester)-2-(4-Me-O-PEG3)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35b), 1,3-O-bis(phosphodiester-2,2-bis(Me-O-mPEG2)-propane (compound 45b), 1,3-O-bis(phosphodiester-2S—O-(PEG4-O-Bz)-propane (compound 38b), 1,3-O-bis(phosphodiester)-2s-O-mPEG6-propane (compound 12c), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG3)-1-(Et-2,2,2-Tris-(Me-O-Bz))-1,2,3-triazole)-propane (compound 37a), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG3)-1-(Me-acetate)-1,2,3-triazole)-propane (compound 35e), 1,3-O-bis(phosphodiester)-2s-O-(4-(Me-O-PEG2)-1-(Et-OBz)-1,2,3-triazole)-propane (compound 35a), 1,3-O-bis(phosphodiester)-2-(4-Et-1-(Et-O-mPEG1)-1,2,3-triazole)-propane (compound 31a), 2,3-O-bis(phosphodiester)-1-(1 dimethoxyquinazolinedione)-propane (compound 20c), 2,3-O-bis(phosphodiester)-1-(N9-(3,6-dimethoxycarbazole)-propane (compound 20e), 1,1′-O-bis(phosphodiester)-2,2′-(sulfonylbis(benz-4-yl))-diethanol (compound 26d), 1,1′-O-bis(phosphodiester)-2,2′-bipyridin-4,4′-yl)-dimethanol (compound 26a), 2,3-O-bis(phosphodiester)-1-(N1-(4,6-dimethoxy-3-Me-indole)-propane (compound 20b), 3-(1,2-O-bis(phosphodiester)-propyl)-8,8-dimethylhexahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide (compound 20d), 2,3-O-bis(phosphodiester)-1-(N1-(6-Azathymine))-propane (compound 20f), 1,5-O-bis(phosphodiester)-hexahydrofuro[2,6]furan (compound 23), 1,1′-O-bis(phosphodiester)-octahydro-2,6-dimethyl-3,8:4,7-dimethano-2,6-naphthyridin-4,8-diyl)-dimethanol (compound 26e), 2,3-O-bis(phosphodiester)-1-(N1-(2-Me-5-nitroindole)-propane (compound 20h), 2,3-O-bis(phosphodiester)-1-(N1-(2-Me-5-nitroindole)-propane (compound 20g), 2,3-O-bis(phosphodiester)-1-(5-benzofuran)-propane (compound 20i), 1,2-O-bis(phosphodiester)-3-O-mPEG2-propane (compound 5b), 1,3-O-bis(phosphodiester)-2-(4-Et-1-(Et-O-mPEG3)-1,2,3-triazole)-propane (compound 31b), and 1,3-O-bis(phosphodiester)-3-O-mPEG4-propane (compound 5a).

9 . The compound of claim 1 , wherein the first and second reporter codes are polymers comprising two or more repeat units selected from hexaethylene glycol, ethane, triaethylene glycol, and any of the compounds set forth in Table 1A.

10 . The compound of claim 1 , wherein the first and second reporter codes are polymers comprising two or more repeat units selected from hexaethylene glycol, ethane, triaethylene glycol, and 1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b).

11 . The compound of claim 1 , wherein the first and second reporter codes are polymers comprising a sequence selected from: (i) [(hexaethylene glycol)2(ethane)3(hexaethylene glycol)(triaethylene glycol)], (ii) [(hexaethyleneglycol)2(1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b))2(ethane)(triaethylene glycol)3], (iii) [(hexaethylene glycol)2(1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b))3(ethane)2(hexaethylene glycol)(triaethylene glycol)], and (iv) [(triaethylene glycol)2(ethane)(1,3-O-bis(phosphodiester)-2S—O-mPEG4-propane (compound 12b))6(ethane)7].

12 . The compound claim 1 , wherein Linker A and Linker B are polymers comprising two or more repeat units selected from: spermine (Q), hexaethylene glycol (D), 2-((4-((3-(benzoyloxy)-2-(((1-(3-(benzoyloxy)-2-((benzoyloxy)methyl)-2-((phosphodiester-oxy)methyl)propyl)-1H-1,2,3-triazol-4-yl)methoxy)methyl)-2-((benzoyloxy)methyl)propoxy)methyl)-1H-1,2,3-triazol-1-yl)methyl)-2-O-phosphodiester-propane-1,3-diyl dibenzoate (compound 62), 1,3-O-bis(phosphodiester-2,2-bis(1-Me-4-(Me-O-PEG2-O-Bz)-1,2,3-triazole)-propane (compound 52), 1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35c), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG7)-1-(Et-OBz)-1,2,3-triazole)-propane (compound 35d), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG3)-1-(Et-2,2,2-Tris-(Me-O-Bz))-1,2,3-triazole)-propane (compound 37a), 1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-2,2,2-Tris-(Me-O—Ac))-1,2,3-triazole)-propane (compound 37b), 1,2-O-bis(phosphodiester)-3-(4-(Me-O-PEG3-O-Bz)-1-(1,2,3-triazole))-propane (compound 31d), 1,3-O-bis(phosphodiester-2,2-bis(4-(Me-O-PEG2-O-Me)-1-(Et-O-Bz)-1,2,3-triazole)-propane (compound 47f), 1,3-O-bis(phosphodiester-2,2-bis(4-(Me-O-PEG3-O-Me)-1-(Et-2,2,2-Tris-(Me-O-Bz))-1,2,3-triazole)-propane (compound 47i), 1,2-O-bis(phosphodiester)-3-(4-methylpiperazine-1-yl)-propane (compound 20j), 1,3-O-bis(phosphodiester-2,2-bis(4-(Me-O-PEG3-O-Me)-1-(Et-O-Bz)-1,2,3-triazole)-propane (compound 47g), and 1,1′-O-bis(phosphodiester)-N(p-tolyl)-diethanolamine (compound 26b).

13 . The compound of claim 1 , wherein Linker A and Linker B are polymers comprising two or more repeat units selected from spermine and any of the compounds set forth in Table 1A.

14 . The compound of claim 1 , wherein Linker A and Linker B comprise a polymerase enhancement region comprising two repeat units of spermine.

15 . The compound of claim 1 , wherein Linker A and Linker B comprise a translocation deceleration region comprising two or more repeat units selected from: 1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35c), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG7)-1-(Et-OBz)-1,2,3-triazole)-propane (compound 35d), 1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG3)-1-(Et-2,2,2-Tris-(Me-O-Bz))-1,2,3-triazole)-propane (compound 37a), and 1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-2,2,2-Tris-(Me-O—Ac))-1,2,3-triazole)-propane (compound 37b).

16 . The compound of claim 1 , wherein Linker A and Linker B comprise a translocation deceleration region comprising a polymer selected from: (i) [((hexaethylene glycol) (1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35c))3(hexaethylene glycol)2], (ii) [((hexathylene glycol)(1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-O—Ac)-1,2,3-triazole)-propane (compound 35c))4(hexaethylene glycol)2], (iii) [((hexathylene glycol)(1,3-O-bis(phosphodiester-2s-O-(4-(Me-O-PEG7)-1-(Et-OBz)-1,2,3-triazole)-propane (compound 35d))4(hexaethylene glycol)2], and (iv) [((hexathylene glycol)(1,3-O-bis(phosphodiester-2-(4-(Me-O-PEG5)-1-(Et-2,2,2-Tris-(Me-O—Ac))-1,2,3-triazole)-propane (compound 37b))4(hexaethylene glycol)2].

17 . The compound of claim 1 , wherein Liker A is joined to the oxygen atom of the alpha phosphoramidate by a linkage comprising a triazole.

18 . The compound of claim 1 , wherein Liker B is joined to the nucleobase by a linkage comprising a triazole.

Assignments (2)
CHANGE OF NAME Recorded Nov 1, 2023
From: STRATOS GENOMICS, INC.
To: ROCHE DIAGNOSTICS SEATTLE, INC.
Reel/Frame 065419/0739 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2023
From: ROCHE DIAGNOSTICS SEATTLE, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 065419/0919 →